FDA APPROVED: Doctors say postpartum depression is a condition that can start during pregnancy with symptoms such as feelings of sadness, guilt, loss of energy and difficulty sleeping.
The study found that when taken twice daily for two weeks, women with severe postpartum depression experienced “significant improvements in depressive symptoms” compared to those who were given a placebo.
Researchers say that the women who took the medication saw relief in as early as three days. The study also stated that those improvements were still reported 28 and 45 days later.Share this story
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA approves zuranolone, first pill for postpartum depressionDrugmakers Sage Therapeutics and Biogen hope to change how depression following childbirth is treated.
続きを読む »
First Pill for Postpartum Depression Is Approved by FDAThe pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial.
続きを読む »
A Game-Changing Pill For Postpartum Depression Was Just Approved By The FDAThe FDA has approved Zurzuvae, the first-ever pill for treating postpartum depression. Here’s how it works.
続きを読む »
1st pill for postpartum depression approved by FDAFederal health officials have approved the first pill to specifically treat depression after childbirth.
続きを読む »
FDA approves first-ever pill for postpartum depression in new mothersBiogen and Sage Therapeutics are behind the first FDA-approved pill for treating postpartum depression.
続きを読む »
FDA approves first postpartum depression pill in the US | CNNThe US Food and Drug Administration has approved the medication zuranolone for the treatment of major depressive disorder and severe postpartum depression – making it the first FDA-approved oral pill in the United States specifically for postpartum depression, a serious mental illness that can develop in about 1 in 7 new mothers after childbirth.
続きを読む »